GlassScriptPhysician profile
Puya Davoodi
NPI 1457432601
$27,950.95
in general payments reported to CMS, 2019-2025
34 companies · $15K in 2025
The $15K reported for 2025 was more than what 96% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,736 · 2020: $4,988 · 2021: $2,871 · 2022: $820 · 2023: $1,040 · 2024: $1,222 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,850 · Food and Beverage: $3,210 · Travel and Lodging: $2,718 · Consulting Fee: $1,750 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,850.00 |
| Food and Beverage | $3,209.76 |
| Travel and Lodging | $2,718.24 |
| Consulting Fee | $1,750.00 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $15,322.94 | 2019-2025 | |
| Sanara Medtech INC. | $5,940.08 | 2020-2025 | Celleraterx, Biasurge |
| Allergan, INC. | $2,218.40 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $769.62 | 2019 | |
| Abbvie INC. | $693.05 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm, Botox |
| Wound Management Technologies, INC | $586.36 | 2019 | |
| Revance Therapeutics, INC. | $483.55 | 2024-2025 | Daxxify |
| Smith+Nephew, INC. | $348.93 | 2019-2024 | Stravix, Grafix Pl, Vlp Mini-Mod |
| Integra Lifesciences Corporation | $305.53 | 2020-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Musculoskeletal Transplant Foundation INC. | $183.76 | 2020-2022 | |
| Mentor Worldwide LLC | $164.89 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Tela Bio, INC. | $110.24 | 2022-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Vertex Pharmaceuticals Incorporated | $105.82 | 2024-2025 | |
| Depuy Synthes Sales INC. | $91.90 | 2020-2021 | |
| Galderma Laboratories, L.P. | $89.74 | 2019-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $78.37 | 2021 | |
| Axogen | $72.27 | 2019-2025 | |
| Polynovo North America LLC | $53.04 | 2022-2023 | |
| Rti Surgical, INC | $48.24 | 2023-2024 | |
| Next Science LLC | $36.44 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $30.38 | 2021-2022 | |
| Kci USA, INC. | $27.11 | 2019 | |
| Lifenet Health | $25.93 | 2025 | Theragenesis Wound Matrix |
| Bioventus LLC | $22.69 | 2022 | |
| Organogenesis INC. | $21.98 | 2021 | |
| Hydrofera LLC | $21.42 | 2021 | |
| Baxter Healthcare | $16.71 | 2023 | |
| Osiris Therapeutics INC. | $14.59 | 2019 | |
| Ethicon US, LLC | $13.59 | 2020 | |
| Coopersurgical, INC. | $12.80 | 2021 | |
| Medline Industries LP | $12.56 | 2019 | |
| Medtronic, INC. | $11.76 | 2021 | |
| Sonex Health, INC. | $10.10 | 2024 | Sx-One Microknife |
| Reprise Biomedical, INC. | $6.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Puya Davoodi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.